Work

All patients with AML and FLT3-ITD should be transplanted in first remission. Also in the era of tyrosine kinase inhibitors? – the PRO

Year: 2026

Type: article

Abstract: transplanted in first remission.Also in the era of tyrosine kinase inhibitors?the PRO by

Source: Haematologica

DOI: 10.3324/haematol.2025.288785

Authors: Sabine Kayser, Richard F. Schlenk

Institutions: German Cancer Research Center, Heidelberg University, German Red Cross, National Center for Tumor Diseases, Medizinische Fakultät Mannheim, University Hospital Heidelberg

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: Pfizer, AstraZeneca, Jazz Pharmaceuticals, PharmaMar, Daiichi Sankyo Europe

OpenAlex ID: W7124316432

FWCI:

Cites:

Cited by:

Related to: